Cardiff Oncology, Inc.
CRDF- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213037
In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Cardiff Oncology, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 117
- +9 vs. Q4 2025
- Shares held
- 24.6M
- +1.07M (+4.6%) vs. Q4 2025
- Total value
- $39.7M
- −$26.4M (−39.9%) vs. Q4 2025
- New holders
- 23
- 30 more added
- Sold out
- 14
- 37 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRDF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 104 | $24.2M |
| Q1 2026 | 117 | $39.7M |
| Q4 2025 | 110 | $76.6M |
| Q3 2025 | 112 | $51.9M |
| Q2 2025 | 115 | $90.3M |
| Q1 2025 | 116 | $101.6M |
| Q4 2024 | 117 | $121.9M |
| Q3 2024 | 83 | $34.1M |
| Q2 2024 | 90 | $29.1M |
| Q1 2024 | 77 | $45.8M |
| Q4 2023 | 55 | $7.84M |
| Q3 2023 | 56 | $7.58M |
| Q2 2023 | 53 | $8.81M |
| Q1 2023 | 55 | $11.6M |
| Q4 2022 | 60 | $10.8M |
| Q3 2022 | 58 | $12.2M |
| Q2 2022 | 67 | $19.6M |
| Q1 2022 | 91 | $41.0M |
| Q4 2021 | 87 | $132.1M |
| Q3 2021 | 94 | $140.7M |
| Q2 2021 | 90 | $176.4M |
| Q1 2021 | 73 | $223.0M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Cardiff Oncology, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Investments, LP | 206,990 | $335.3K | 0.00% | −517,967−71.4% | Reduced |
| XTX Topco Ltd | 250,222 | $405.4K | 0.01% | +30,865+14.1% | Added |
| Bank of New York Mellon Corp | 303,428 | $491.6K | 0.00% | −25,567−7.8% | Reduced |
| UBS Group AG | 400,576 | $648.9K | 0.00% | +313,147+358.2% | Added |
| Vanguard Portfolio Management LLC | 437,214 | $708.3K | 0.00% | +437,214 | New |
| Vanguard Fiduciary Trust Co | 446,225 | $722.9K | 0.00% | +446,225 | New |
| Northern Trust Corp | 493,205 | $799.0K | 0.00% | +31,452+6.8% | Added |
| Flputnam Investment Management Co | 595,127 | $964.1K | 0.01% | −2010.0% | Reduced |
| Blair William & Co | 922,407 | $1.49M | 0.00% | −1,026,440−52.7% | Reduced |
| State Street Corp | 1,186,947 | $1.92M | 0.00% | −4,700−0.4% | Reduced |
| Franklin Resources Inc | 1,205,803 | $1.95M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,599,663 | $2.59M | 0.00% | +76,648+5.0% | Added |
| Acorn Capital Advisors, LLC | 1,762,084 | $2.85M | 0.81% | −200,000−10.2% | Reduced |
| Pfizer Inc | 2,411,575 | $3.74M | 1.57% | 00.0% | Unchanged |
| Laurion Capital Management LP | 2,646,738 | $4.29M | 0.40% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 2,855,966 | $4.63M | 0.00% | +2,855,966 | New |
| BlackRock, Inc. | 3,981,387 | $6.45M | 0.00% | −62,227−1.5% | Reduced |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −360,500−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −344,437−100.0% | Sold out |
| HB Wealth Management, LLC | 0 | $0 | 0.00% | −71,491−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −29,408−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −12,649−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −11,778−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,328−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −6,490−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −6,230−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,948−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Front Row Advisors LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Motiv8 Investments LLC | – | – | – | – | Not filed |